Factor XIII deficiency, a rare coagulopathy: case reports

Daniela De Oliveira Werneck Rodrigues, Isabella Boa Sorte Costa, Samara de Paula Silva Souza, Amanda Do Carmo Gusmão
{"title":"Factor XIII deficiency, a rare coagulopathy: case reports","authors":"Daniela De Oliveira Werneck Rodrigues, Isabella Boa Sorte Costa, Samara de Paula Silva Souza, Amanda Do Carmo Gusmão","doi":"10.34019/1982-8047.2023.v49.43058","DOIUrl":null,"url":null,"abstract":"Introduction: Hereditary Factor XIII (FXIII) deficiency is a rare autosomal recessive hemostatic disorder with an estimated incidence of one case per two million individuals and a higher prevalence in descendants of consanguineous relationships. Possible clinical manifestations include intracranial hemorrhage, umbilical cord bleeding at birth, hematoma, spontaneous abortions, and menometrorrhagia. Objective: To highlight the peculiarities of this hemostatic disorder, as well as the recommended management. Case Report: The authors describe two cases of FXIII deficiency with different hemorrhagic manifestations. Case 1 presented extensive spontaneous hematoma in the right thigh, while Case 2 had umbilical cord bleeding at birth and intracranial hemorrhage, requiring hemotherapy support. Both patients had normal results in screening laboratory tests for coagulation disorders. Coagulation factor serum levels and diagnostic assessments identified mild Factor XIII deficiency in Case 1 and severe deficiency in Case 2. The patient in Case 1 is under regular control and follow-up, while the patient in Case 2 is on a monthly prophylactic regimen with FXIII infusion. Conclusion: The diagnosis of FXIII deficiency in patients with significant bleeding should be considered if screening coagulation tests are normal. The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis has established an algorithm for laboratory diagnosis and identification of different forms of FXIII deficiency. Quantitative determination of FXIII activity, antigenic assays, and molecular studies are necessary.","PeriodicalId":34488,"journal":{"name":"HU Revista","volume":"99 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HU Revista","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34019/1982-8047.2023.v49.43058","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Hereditary Factor XIII (FXIII) deficiency is a rare autosomal recessive hemostatic disorder with an estimated incidence of one case per two million individuals and a higher prevalence in descendants of consanguineous relationships. Possible clinical manifestations include intracranial hemorrhage, umbilical cord bleeding at birth, hematoma, spontaneous abortions, and menometrorrhagia. Objective: To highlight the peculiarities of this hemostatic disorder, as well as the recommended management. Case Report: The authors describe two cases of FXIII deficiency with different hemorrhagic manifestations. Case 1 presented extensive spontaneous hematoma in the right thigh, while Case 2 had umbilical cord bleeding at birth and intracranial hemorrhage, requiring hemotherapy support. Both patients had normal results in screening laboratory tests for coagulation disorders. Coagulation factor serum levels and diagnostic assessments identified mild Factor XIII deficiency in Case 1 and severe deficiency in Case 2. The patient in Case 1 is under regular control and follow-up, while the patient in Case 2 is on a monthly prophylactic regimen with FXIII infusion. Conclusion: The diagnosis of FXIII deficiency in patients with significant bleeding should be considered if screening coagulation tests are normal. The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis has established an algorithm for laboratory diagnosis and identification of different forms of FXIII deficiency. Quantitative determination of FXIII activity, antigenic assays, and molecular studies are necessary.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
因子 XIII 缺乏症--一种罕见的凝血病:病例报告
导言:遗传性因子 XIII(FXIII)缺乏症是一种罕见的常染色体隐性止血疾病,估计发病率为每 200 万人中有一例,在近亲结婚的后代中发病率较高。可能的临床表现包括颅内出血、出生时脐带出血、血肿、自然流产和子宫出血。目的:强调这种止血障碍的特殊性以及建议的处理方法。病例报告:作者描述了两例具有不同出血表现的 FXIII 缺乏症病例。病例 1 右大腿出现广泛自发性血肿,而病例 2 出生时出现脐带出血和颅内出血,需要血液疗法支持。两名患者的凝血功能障碍筛查化验结果均正常。凝血因子血清水平和诊断评估发现,病例 1 患有轻度因子 XIII 缺乏症,病例 2 患有重度因子 XIII 缺乏症。病例 1 的患者正在接受定期控制和随访,而病例 2 的患者正在接受每月输注 FXIII 的预防性治疗。结论如果筛查凝血试验正常,则应考虑诊断有明显出血症状的患者是否患有 FXIII 缺乏症。国际血栓与止血学会科学与标准化委员会已制定了实验室诊断和识别不同形式 FXIII 缺乏症的算法。FXIII 活性的定量测定、抗原检测和分子研究都是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
8
审稿时长
16 weeks
期刊最新文献
Aspectos clínicos e diagnósticos, qualidade de vida, utilidade, adesão terapêutica e custos para angioedema hereditário associado à deficiência de C1-esterase Avaliação da eficácia e segurança de pegaspargase, em comparação à L-asparaginase, e sua viabilidade econômica no tratamento de leucemia linfoblástica aguda Suporte básico de vida para estudantes de escolas públicas e privadas durante a pandemia do SARS-CoV-2 Vírus Epstein-Barr associado ao Linfoma de Hodgkin clássico: um estudo de casos Associação do risco nutricional com parâmetros clínicos e nutricionais de pacientes internados em um hospital universitário
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1